Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of NLS Pharmaceutics's Quilience?
Quilience is a small molecule commercialized by NLS Pharmaceutics, with a leading Phase II program in Narcolepsy;Idiopathic Hypersomnia (IH). According...
Data Insights
Risk adjusted net present value: What is the current valuation of NLS Pharmaceutics's Quilience?
Quilience is a small molecule commercialized by NLS Pharmaceutics, with a leading Phase II program in Type 1 Narcolepsy (Narcolepsy...